clinical trial · NCT03662620
Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers
HypertensionTelmisartan 80mg + Amlodipine 5mg + Chlorthalidone 25mgTelmisartan 80mg + Amlodipine 5mg + Chlorthalidone 25mg
brief summary
This is a phase 1, randomized, open label, single-dose, replicate crossover clinical trial to compare the safety and pharmacokinetics of YH22162 in healthy male volunteers. Hypothesis: Study drug and comparator drug are showing equal pharmacokinetics.
started
Oct 5, 2018
primary completion
Dec 8, 2018
completion
Dec 22, 2018
last updated
Nov 12, 2024
detailed description
In ARM1, 32 subjects will be assigned and the subjects will be administered "comparator drug" at Day1/Day43 and "study drug" at Day22/64.
In ARM2, 32 subjects will be assigned and the subjects will be administered "study drug" at Day1/Day43 and "comparator drug" at Day22/64.
official title
A Randomized, Open-label, Single Dose, Replicate Crossover Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol